NanJing Pharmaceutical Company Limited (SHA:600713)

SHA:600713 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,306	4,563	2,372	2,328	2,095	1,482
Cash & Short-Term Investments	2,388	4,563	2,372	2,328	2,095	1,482
Cash Growth	-2.98%	92.39%	1.87%	11.13%	41.32%	-29.52%
Accounts Receivable	19,595	15,098	16,209	19,304	15,251	14,262
Other Receivables	-134.6	97.9	29.71	29.28	22.86	27.39
Receivables	19,461	15,196	16,238	19,334	15,274	14,289
Inventory	6,161	6,286	5,798	5,787	4,518	4,065
Other Current Assets	2,179	1,764	1,605	1,813	1,571	1,328
Total Current Assets	30,189	27,808	26,013	29,261	23,458	21,165
Property, Plant & Equipment	2,046	1,885	1,507	1,519	1,492	1,187
Long-Term Investments	266.73	283.47	237.64	206.45	254.18	324.12
Goodwill	72.17	72.17	72.17	72.17	72.17	74.17
Other Intangible Assets	207.34	215.68	218.98	245.28	268.11	282.17
Long-Term Deferred Tax Assets	257.63	243.43	222.82	224.93	180.78	185.92
Long-Term Deferred Charges	77.95	63.07	43.34	36.89	34.24	52.76
Other Long-Term Assets	89.65	102.74	95.58	84.69	126.24	138.93
Total Assets	33,206	30,674	28,410	31,651	25,886	23,410
Accounts Payable	10,166	10,176	9,694	10,131	8,064	7,634
Accrued Expenses	288.42	369.49	363.63	438.32	379.33	315.11
Short-Term Debt	8,060	3,760	4,574	8,414	7,036	7,642
Current Portion of Long-Term Debt	195.14	900.98	2,223	1,409	-	-
Current Portion of Leases	83.58	79.63	76.04	71.68	78.28	1.04
Current Income Taxes Payable	99.13	87.6	91.48	102.89	136.01	108.7
Current Unearned Revenue	240.31	278.67	103.57	219.12	74.78	75.24
Other Current Liabilities	1,564	1,441	1,441	1,498	1,756	1,427
Total Current Liabilities	20,697	17,094	18,566	22,284	17,525	17,203
Long-Term Debt	4,112	5,339	2,118	2,222	2,628	1,027
Long-Term Leases	215.07	116.18	119.02	103.23	124.4	2.51
Long-Term Unearned Revenue	269.49	277.62	297.06	293.17	304.61	265.33
Long-Term Deferred Tax Liabilities	58.44	59.05	55.41	54.24	69.9	92.1
Total Liabilities	25,352	22,886	21,155	24,956	20,652	18,589
Common Stock	1,309	1,309	1,310	1,310	1,042	1,042
Additional Paid-In Capital	2,142	2,466	2,460	2,429	1,380	1,652
Retained Earnings	3,041	2,973	2,611	2,217	1,778	1,388
Treasury Stock	-48.34	-20.9	-35.9	-38.58	-	-
Comprehensive Income & Other	415.66	111.24	89.72	81.98	406.6	176.6
Total Common Equity	6,860	6,838	6,435	6,000	4,606	4,258
Minority Interest	994.41	949.87	819.73	695.03	627.46	562.59
Shareholders' Equity	7,854	7,788	7,255	6,695	5,234	4,820
Total Liabilities & Equity	33,206	30,674	28,410	31,651	25,886	23,410
Total Debt	12,666	10,196	9,110	12,219	9,867	8,673
Net Cash (Debt)	-10,278	-5,634	-6,738	-9,891	-7,772	-7,190
Net Cash Per Share	-7.45	-4.32	-5.19	-7.89	-7.46	-6.90
Filing Date Shares Outstanding	1,309	1,309	1,310	1,310	1,042	1,042
Total Common Shares Outstanding	1,309	1,309	1,310	1,310	1,042	1,042
Working Capital	9,492	10,714	7,447	6,978	5,933	3,962
Book Value Per Share	5.24	5.22	4.91	4.58	4.42	4.09
Tangible Book Value	6,580	6,550	6,144	5,682	4,266	3,901
Tangible Book Value Per Share	5.03	5.00	4.69	4.34	4.10	3.75
Buildings	1,471	1,463	1,133	1,166	1,046	-
Machinery	938.72	928.24	890.32	839.29	762.13	-
Construction In Progress	342.99	237.27	130.08	80.23	153.4	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.